Multiple sclerosis (MS) is an immune‐mediated disorder of the central nervous system. DMTs effectively reduce the annual relapse rate—thus reducing disease activity—and, to a lesser extent, some DMTs prevent disease… Click to show full abstract
Multiple sclerosis (MS) is an immune‐mediated disorder of the central nervous system. DMTs effectively reduce the annual relapse rate—thus reducing disease activity—and, to a lesser extent, some DMTs prevent disease progression in some people with MS. Monitoring the efficacy of DMTs with no evidence disease activity (NEDA) provides an objective perspective for evaluating treatment success.
Keywords:
neda assessment;
relapsing neda;
dmts;
injectable dmts;
self injectable;
dmts relapsing
Journal Title: Acta Neurologica Scandinavica
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Acta Neurologica Scandinavica
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!